Currently Chief Executive Officer of STE Health International, LLC and Director of Research & Innovation for the World Health Organization Collaboration Center, UNC-CH.
Previously Company Head & Chief Scientific Officer Ortho-McNeil Janssen Scientific Affairs, LLC, and member Johnson & Johnson's North American Pharmaceutical Management board, covering J&J companies focusing on neurology, psychiatry, analgesia, anti-infectives, gastroenterology, women's health, urology, pediatrics & cardiovascular diseases. Serve on Board of Directors of American Foundation for Pharmaceutical Education & member of the Centers for Disease Control Foundation's Corporate Roundtable.
Academic appointments: Adjunct Professorships UNC School of Public Health, Rutgers University School of Pharmacy, and University of Pennsylvania, School of Medicine.
Was Medical Epidemiologist in CDC's Chronic Disease Division, engaging in research ranging from pregnancy-related mortality to Vietnam combat. Initial J&J role: pharmaceutical development responsible for a number of novel product approvals.
Research interests: geriatrics/gerontology, pharmacoepidemiology, clinical trial design, clinical project planning & execution, & management of technical profess